Grove Bank & Trust’s Edwards Lifesciences EW Stock Holding History

Grove Bank & Trust’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$91.3K	Hold	1,009	–	–	0.01%	355
2026 Q1	$80.8K	Hold	1,009	–	–	0.01%	367
2025 Q4	$86K	Hold	1,009	–	–	0.01%	354
2025 Q3	$78.5K	Hold	1,009	–	–	0.01%	363
2025 Q2	$78.9K	Buy	1,009 +48	+5%	+$3.58K	0.01%	369
2025 Q1	$69.7K	Hold	961	–	–	0.01%	368
2024 Q4	$71.1K	Buy	961 +29	+3%	+$2.03K	0.01%	331
2024 Q3	$61.5K	Buy	932 +82	+10%	+$5.96K	0.01%	346
2024 Q2	$78.5K	Sell	850 -10	-1%	-$886	0.01%	303
2024 Q1	$82.2K	Hold	860	–	–	0.01%	312
2023 Q4	$65.6K	Hold	860	–	–	0.01%	326
2023 Q3	$59.6K	Sell	860 -71	-8%	-$5.71K	0.01%	339
2023 Q2	$87.8K	Sell	931 -15	-2%	-$1.3K	0.02%	305
2023 Q1	$78.3K	Buy	946 +53	+6%	+$4.17K	0.02%	316
2022 Q4	$67K	Buy	+893	New	+$68.8K	0.01%	334
2018 Q1	–	Sell	-510	Closed	-$19K	–	262
2017 Q4	$19K	Hold	510	–	–	0.01%	391
2017 Q3	$19K	Hold	510	–	–	0.01%	402
2017 Q2	$20K	Buy	510 +330	+183%	+$12K	0.01%	377
2017 Q1	$6K	Hold	180	–	–	﹤0.01%	393
2016 Q4	$6K	Buy	+180	New	+$5.83K	﹤0.01%	430

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Grove Bank & Trust's EW Position: Q2 2026 in Review

Grove Bank & Trust held its Edwards Lifesciences (EW) position steady in Q2 2026 at 1,009 shares worth $91.3K. The position accounts for 0.01% of the portfolio, ranked #355.

Grove Bank & Trust first reported a position in EW in Q4 2016 and has held it in 20 quarters since. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Grove Bank & Trust held 1,009 shares of Edwards Lifesciences worth $91.3K as of Q2 2026.
Grove Bank & Trust left its Edwards Lifesciences share count unchanged in Q2 2026.
Edwards Lifesciences made up 0.01% of Grove Bank & Trust's portfolio in Q2 2026, its #355 holding.
Grove Bank & Trust first reported a position in Edwards Lifesciences in Q4 2016 and has held it in 20 quarters since.
1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Grove Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.